Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia

导出原文传递

翻译打印收藏纠错

作者： Quintarelli,C. ^[1] ; DeAngelis,B. ^[2] ; Errichiello,S. ^[3] ; Caruso,S. ^[4] ; Esposito,N. ^[5] ; Colavita,I. ; Raia,M. ; Pagliuca,S. ; Pugliese,N. ; Risitano,A.M. ; Picardi,M. ; Luciano,L. ; Saglio,G. ; Martinelli,G. ; Pane,F.

作者单位： Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, Italy, CEINGE ^[1] CEINGE Biotecnologie Avanzate, Napoli, Italy ^[2] Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy ^[3] Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, Italy ^[4] Dept. of Haematology/Oncology L. e A. Seràgnoli, University of Bologna, Bologna, Italy ^[5]

关键词 BM microenvironment Chronic myelogenous leukemia Resistance Tyrosine kinase inhibitor

发布时间 2014-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交